Medicamen Biotech Limited (MEDICAMEQ.NS)

INR 458.15

(-8.44%)

Long Term Debt Summary of Medicamen Biotech Limited

  • Medicamen Biotech Limited's latest annual long term debt in 2023 was 12.55 Million INR , up 44.38% from previous year.
  • Medicamen Biotech Limited's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Medicamen Biotech Limited reported annual long term debt of 8.69 Million INR in 2022, down -82.86% from previous year.
  • Medicamen Biotech Limited reported annual long term debt of 50.73 Million INR in 2021, down -20.78% from previous year.
  • Medicamen Biotech Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.
  • Medicamen Biotech Limited reported quarterly long term debt of 19.27 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Medicamen Biotech Limited (2023 - 2008)

Historical Annual Long Term Debt of Medicamen Biotech Limited (2023 - 2008)

Year Long Term Debt Long Term Debt Growth
2023 12.55 Million INR 44.38%
2022 8.69 Million INR -82.86%
2021 50.73 Million INR -20.78%
2020 64.04 Million INR 171.55%
2019 23.58 Million INR 11163.29%
2018 209.39 Thousand INR -85.23%
2017 1.41 Million INR -94.25%
2016 24.63 Million INR -29.91%
2015 35.15 Million INR -23.41%
2014 45.89 Million INR 2858.16%
2013 1.55 Million INR -4.8%
2012 1.62 Million INR -12.3%
2011 1.85 Million INR -98.11%
2010 98.1 Million INR -22.78%
2009 127.04 Million INR 44.82%
2008 87.72 Million INR 0.0%

Peer Long Term Debt Comparison of Medicamen Biotech Limited

Name Long Term Debt Long Term Debt Difference
Alembic Pharmaceuticals Limited 628.8 Million INR 98.003%
Bafna Pharmaceuticals Limited 107.53 Million INR 88.324%
FDC Limited 2.46 Million INR -409.124%
Gufic Biosciences Limited 1.53 Billion INR 99.185%
Jubilant Pharmova Limited 31.67 Billion INR 99.96%
Nectar Lifesciences Limited 1.4 Billion INR 99.105%
Orchid Pharma Limited 1.2 Billion INR 98.957%
Alkem Laboratories Limited 400 Million INR 96.861%
Bajaj HealthCare Limited 650.34 Million INR 98.069%
Brooks Laboratories Limited 3.56 Million INR -252.174%
Eris Lifesciences Limited 6.54 Billion INR 99.808%
Glenmark Life Sciences Limited 147.61 Million INR 91.494%
Solara Active Pharma Sciences Limited 1.17 Billion INR 98.931%
Innova Captab Limited 2.1 Billion INR 99.404%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 83.386%
Wanbury Limited 820 Million INR 98.469%
Lupin Limited 1.55 Billion INR 99.191%
Aarti Drugs Limited 2.75 Billion INR 99.544%
Aarti Pharmalabs Limited 400 Thousand INR -3038.75%
Albert David Limited 6.01 Million INR -108.693%
Alembic Limited 73.9 Million INR 83.011%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Hester Biosciences Limited 1.81 Billion INR 99.309%
Hikal Limited 4.22 Billion INR 99.703%
Ind-Swift Laboratories Limited 111.62 Million INR 88.753%
Ind-Swift Limited 10.09 Billion INR 99.876%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Kilitch Drugs (India) Limited - INR -Infinity%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Mangalam Drugs & Organics Limited 133.54 Million INR 90.598%
Medico Remedies Limited 8.67 Million INR -44.776%
Morepen Laboratories Limited 33.64 Million INR 62.678%
Procter & Gamble Health Limited 68.8 Million INR 81.751%
RPG Life Sciences Limited -30.3 Million INR 141.436%
Sigachi Industries Limited 265.79 Million INR 95.276%
Sun Pharmaceutical Industries Limited 13.3 Million INR 5.602%
Suven Pharmaceuticals Limited 212.35 Million INR 94.088%
Themis Medicare Limited 267.74 Million INR 95.311%
Unichem Laboratories Limited 382.22 Million INR 96.715%
Vaishali Pharma Limited 35.98 Million INR 65.109%
Venus Remedies Limited 386.8 Million INR 96.754%
Windlas Biotech Limited 20.18 Million INR 37.785%
ZIM Laboratories Limited 356 Million INR 96.473%
Sakar Healthcare Limited 549.55 Million INR 97.715%
Aurobindo Pharma Limited 21.34 Billion INR 99.941%
Divi's Laboratories Limited 20 Million INR 37.225%
AstraZeneca Pharma India Limited 27.83 Million INR 54.897%
Mankind Pharma Limited 325.81 Million INR 96.147%
Sequent Scientific Limited 1.42 Billion INR 99.12%
Laurus Labs Limited 7.98 Billion INR 99.843%
Neuland Laboratories Limited 449.2 Million INR 97.205%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 94.689%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 99.172%
Zydus Lifesciences Limited 251 Million INR 94.998%
Amrutanjan Health Care Limited 13.96 Million INR 10.116%
Wockhardt Limited 8.91 Billion INR 99.859%
Bal Pharma Limited 363.82 Million INR 96.549%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.79%
Bliss GVS Pharma Limited 355.92 Million INR 96.473%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 9.2 Million INR -36.467%
Shilpa Medicare Limited 5.6 Billion INR 99.776%
Valiant Laboratories Limited 750.89 Million INR 98.328%
Ajanta Pharma Limited 235.2 Million INR 94.662%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 61.062%
Granules India Limited 689.71 Million INR 98.18%
Ipca Laboratories Limited 5.8 Billion INR 99.784%
Syncom Formulations (India) Limited -1.21 Million INR 1129.943%
Piramal Enterprises Limited 535.85 Billion INR 99.998%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.922%
NATCO Pharma Limited 53 Million INR 76.311%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 99.316%
Strides Pharma Science Limited 6.71 Billion INR 99.813%
Indoco Remedies Limited 3.51 Billion INR 99.643%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 88.222%